MetLife, Inc.
MET · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.06 | -0.45 | -0.61 | 0.22 |
| FCF Yield | 26.79% | 28.28% | 20.17% | 24.86% |
| EV / EBITDA | 7.47 | 12.38 | 6.79 | 4.83 |
| Quality | ||||
| ROIC | 1.02% | 0.51% | 0.56% | 1.74% |
| Gross Margin | 27.17% | 25.53% | 27.86% | 26.57% |
| Cash Conversion Ratio | 3.42 | 9.04 | 2.15 | 1.96 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.96% | 2.23% | 0.04% | -3.09% |
| Free Cash Flow Growth | 6.00% | 25.38% | -11.34% | 11.46% |
| Safety | ||||
| Net Debt / EBITDA | -0.18 | -0.46 | -0.28 | -0.26 |
| Interest Coverage | 5.42 | 2.07 | 6.78 | 9.26 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 160.58 | 162.77 | 93.48 | 99.84 |